US Stock MarketDetailed Quotes

VYGR Voyager Therapeutics

Watchlist

5.890
+0.120+2.08%

Close Sep 26 16:00 ET

5.940
+0.050+0.85%

Post 20:02 ET

321.20MMarket Cap21.81P/E (TTM)

Voyager Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-3,682.04%-31.58M

-52.44%58.77M

722.90%77.92M

-94.05%-23.76M

-29.90%-21.05M

95.48%-835K

258.93%123.57M

76.63%-12.51M

-209.37%-12.24M

21.75%-16.21M

Net income from continuing operations

54.34%-10.14M

-109.13%-11.33M

385.14%132.33M

338.70%56.4M

-246.96%-25.9M

-16.35%-22.21M

681.85%124.04M

34.82%-46.41M

-513.84%-23.63M

170.11%17.62M

Operating gains losses

183.75%227K

34.09%59K

-52.79%178K

--35K

--19K

--80K

--44K

--377K

----

Depreciation and amortization

28.18%1.39M

11.26%1.2M

-28.27%4.44M

60.07%1.34M

-29.53%945K

-9.80%1.09M

-61.77%1.08M

19.86%6.19M

-43.72%834K

9.56%1.34M

Other non cash items

----

-0.33%-2.47M

--0

Change In working capital

-256.26%-27.41M

1,723.58%67.2M

-425.13%-66.56M

-1,158.79%-82.78M

107.54%2.82M

2,999.67%17.54M

-108.18%-4.14M

521.46%20.47M

236.26%7.82M

-3,778.33%-37.34M

-Change in receivables

-99.06%206K

419.23%80.03M

-17,622.95%-83.23M

-904.96%-80.24M

100.96%97K

39,860.00%21.98M

-4,866.35%-25.07M

-93.48%475K

2,202.08%9.97M

-1,798.82%-10.07M

-Change in prepaid assets

43.44%-1.19M

-156.27%-794K

103.86%76K

232.70%418K

120.75%344K

-1,197.91%-2.1M

862.70%1.41M

-204.46%-1.97M

-307.24%-315K

-297.85%-1.66M

-Change in payables and accrued expense

-257.33%-2.22M

-429.70%-3.33M

795.93%8.05M

218.81%4.11M

-33.09%3.55M

-343.57%-621K

135.22%1.01M

65.95%-1.16M

-683.45%-3.46M

2,048.58%5.31M

-Change in other current assets

184.84%1.39M

122.17%1.04M

-40.33%1.98M

69.18%516K

11.80%502K

-66.94%488K

-56.57%469K

23.74%3.31M

-10.56%305K

30.90%449K

-Change in other current liabilities

-41.74%-995K

230.45%891K

27.77%-2.83M

-48.88%-731K

-44.27%-717K

56.85%-702K

47.74%-683K

-14.41%-3.92M

54.54%-491K

-8.75%-497K

-Change in other working capital

-1,537.26%-24.61M

-156.84%-10.64M

-60.33%9.41M

-479.07%-6.85M

96.88%-962K

-168.39%-1.5M

-64.90%18.73M

1,478.91%23.73M

-38.15%1.81M

-5,521.49%-30.86M

Cash from discontinued investing activities

Operating cash flow

-3,682.04%-31.58M

-52.44%58.77M

722.90%77.92M

-94.05%-23.76M

-29.90%-21.05M

95.48%-835K

258.93%123.57M

76.63%-12.51M

-209.37%-12.24M

21.74%-16.21M

Investing cash flow

Cash flow from continuing investing activities

-45.74%-35.94M

-762.93%-96.07M

-1,830.00%-141.64M

90.75%26.83M

-555.92%-158.3M

31.74%-24.66M

172.46%14.49M

-111.14%-7.34M

357.45%14.07M

142.13%34.72M

Net PPE purchase and sale

20.08%-967K

-320.63%-2.14M

-30.71%-3.26M

19.08%-755K

-181.29%-782K

2.58%-1.21M

-1,239.47%-509K

-54.82%-2.49M

-168.88%-933K

57.88%-278K

Net investment purchase and sale

-49.13%-34.98M

-726.16%-93.92M

-2,754.52%-138.39M

83.92%27.59M

-550.06%-157.52M

32.78%-23.45M

175.15%15M

-107.18%-4.85M

393.14%15M

133.33%35M

Cash from discontinued investing activities

Investing cash flow

-45.74%-35.94M

-762.93%-96.07M

-1,830.00%-141.64M

90.75%26.83M

-555.92%-158.3M

31.74%-24.66M

172.46%14.49M

-111.14%-7.34M

357.45%14.07M

142.13%34.72M

Financing cash flow

Cash flow from continuing financing activities

-63.11%571K

260.49%112.86M

2,931.08%33.65M

66.67%460K

2,106.67%331K

91.82%1.55M

260,783.33%31.31M

81.37%1.11M

21.59%276K

15K

Net common stock issuance

--0

262.39%112.78M

--31.12M

--0

--31.12M

--0

----

Proceeds from stock option exercised by employees

-63.11%571K

-57.84%78K

127.39%2.52M

66.67%460K

2,106.67%331K

91.82%1.55M

1,441.67%185K

81.37%1.11M

21.59%276K

--15K

Cash from discontinued financing activities

Financing cash flow

-63.11%571K

260.49%112.86M

2,931.08%33.65M

66.67%460K

2,106.67%331K

91.82%1.55M

260,783.33%31.31M

81.37%1.11M

21.59%276K

--15K

Net cash flow

Beginning cash position

-45.91%145.95M

-29.94%70.4M

-15.72%100.47M

-32.03%66.86M

207.96%245.89M

101.89%269.84M

-15.72%100.47M

12.23%119.21M

-13.14%98.38M

-33.25%79.84M

Current changes in cash

-179.55%-66.95M

-55.39%75.56M

-60.52%-30.08M

68.32%3.53M

-1,066.08%-179.02M

55.49%-23.95M

1,072.87%169.36M

-244.22%-18.74M

-64.77%2.1M

390.96%18.53M

End cash Position

-67.87%79M

-45.91%145.95M

-29.94%70.4M

-32.03%66.86M

207.96%245.89M

101.89%269.84M

-15.72%100.47M

-13.14%98.38M

Free cash flow

-1,491.54%-32.55M

-53.98%56.63M

597.75%74.66M

-86.04%-24.52M

-32.45%-21.83M

89.63%-2.05M

257.85%123.06M

72.79%-15M

-221.47%-13.18M

22.86%-16.48M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-3,682.04%-31.58M	-52.44%58.77M	722.90%77.92M	-94.05%-23.76M	-29.90%-21.05M	95.48%-835K	258.93%123.57M	76.63%-12.51M	-209.37%-12.24M	21.75%-16.21M
Net income from continuing operations	54.34%-10.14M	-109.13%-11.33M	385.14%132.33M	338.70%56.4M	-246.96%-25.9M	-16.35%-22.21M	681.85%124.04M	34.82%-46.41M	-513.84%-23.63M	170.11%17.62M
Operating gains losses	183.75%227K	34.09%59K	-52.79%178K	--35K	--19K	--80K	--44K	--377K	----	----
Depreciation and amortization	28.18%1.39M	11.26%1.2M	-28.27%4.44M	60.07%1.34M	-29.53%945K	-9.80%1.09M	-61.77%1.08M	19.86%6.19M	-43.72%834K	9.56%1.34M
Other non cash items	----	----	----	----	----	----	----	-0.33%-2.47M	--0	--0
Change In working capital	-256.26%-27.41M	1,723.58%67.2M	-425.13%-66.56M	-1,158.79%-82.78M	107.54%2.82M	2,999.67%17.54M	-108.18%-4.14M	521.46%20.47M	236.26%7.82M	-3,778.33%-37.34M
-Change in receivables	-99.06%206K	419.23%80.03M	-17,622.95%-83.23M	-904.96%-80.24M	100.96%97K	39,860.00%21.98M	-4,866.35%-25.07M	-93.48%475K	2,202.08%9.97M	-1,798.82%-10.07M
-Change in prepaid assets	43.44%-1.19M	-156.27%-794K	103.86%76K	232.70%418K	120.75%344K	-1,197.91%-2.1M	862.70%1.41M	-204.46%-1.97M	-307.24%-315K	-297.85%-1.66M
-Change in payables and accrued expense	-257.33%-2.22M	-429.70%-3.33M	795.93%8.05M	218.81%4.11M	-33.09%3.55M	-343.57%-621K	135.22%1.01M	65.95%-1.16M	-683.45%-3.46M	2,048.58%5.31M
-Change in other current assets	184.84%1.39M	122.17%1.04M	-40.33%1.98M	69.18%516K	11.80%502K	-66.94%488K	-56.57%469K	23.74%3.31M	-10.56%305K	30.90%449K
-Change in other current liabilities	-41.74%-995K	230.45%891K	27.77%-2.83M	-48.88%-731K	-44.27%-717K	56.85%-702K	47.74%-683K	-14.41%-3.92M	54.54%-491K	-8.75%-497K
-Change in other working capital	-1,537.26%-24.61M	-156.84%-10.64M	-60.33%9.41M	-479.07%-6.85M	96.88%-962K	-168.39%-1.5M	-64.90%18.73M	1,478.91%23.73M	-38.15%1.81M	-5,521.49%-30.86M
Cash from discontinued investing activities
Operating cash flow	-3,682.04%-31.58M	-52.44%58.77M	722.90%77.92M	-94.05%-23.76M	-29.90%-21.05M	95.48%-835K	258.93%123.57M	76.63%-12.51M	-209.37%-12.24M	21.74%-16.21M
Investing cash flow
Cash flow from continuing investing activities	-45.74%-35.94M	-762.93%-96.07M	-1,830.00%-141.64M	90.75%26.83M	-555.92%-158.3M	31.74%-24.66M	172.46%14.49M	-111.14%-7.34M	357.45%14.07M	142.13%34.72M
Net PPE purchase and sale	20.08%-967K	-320.63%-2.14M	-30.71%-3.26M	19.08%-755K	-181.29%-782K	2.58%-1.21M	-1,239.47%-509K	-54.82%-2.49M	-168.88%-933K	57.88%-278K
Net investment purchase and sale	-49.13%-34.98M	-726.16%-93.92M	-2,754.52%-138.39M	83.92%27.59M	-550.06%-157.52M	32.78%-23.45M	175.15%15M	-107.18%-4.85M	393.14%15M	133.33%35M
Cash from discontinued investing activities
Investing cash flow	-45.74%-35.94M	-762.93%-96.07M	-1,830.00%-141.64M	90.75%26.83M	-555.92%-158.3M	31.74%-24.66M	172.46%14.49M	-111.14%-7.34M	357.45%14.07M	142.13%34.72M
Financing cash flow
Cash flow from continuing financing activities	-63.11%571K	260.49%112.86M	2,931.08%33.65M	66.67%460K	2,106.67%331K	91.82%1.55M	260,783.33%31.31M	81.37%1.11M	21.59%276K	15K
Net common stock issuance	--0	262.39%112.78M	--31.12M	--0	--0	--0	--31.12M	--0	--0	----
Proceeds from stock option exercised by employees	-63.11%571K	-57.84%78K	127.39%2.52M	66.67%460K	2,106.67%331K	91.82%1.55M	1,441.67%185K	81.37%1.11M	21.59%276K	--15K
Cash from discontinued financing activities
Financing cash flow	-63.11%571K	260.49%112.86M	2,931.08%33.65M	66.67%460K	2,106.67%331K	91.82%1.55M	260,783.33%31.31M	81.37%1.11M	21.59%276K	--15K
Net cash flow
Beginning cash position	-45.91%145.95M	-29.94%70.4M	-15.72%100.47M	-32.03%66.86M	207.96%245.89M	101.89%269.84M	-15.72%100.47M	12.23%119.21M	-13.14%98.38M	-33.25%79.84M
Current changes in cash	-179.55%-66.95M	-55.39%75.56M	-60.52%-30.08M	68.32%3.53M	-1,066.08%-179.02M	55.49%-23.95M	1,072.87%169.36M	-244.22%-18.74M	-64.77%2.1M	390.96%18.53M
End cash Position	-67.87%79M	-45.91%145.95M	-29.94%70.4M	-29.94%70.4M	-32.03%66.86M	207.96%245.89M	101.89%269.84M	-15.72%100.47M	-15.72%100.47M	-13.14%98.38M
Free cash flow	-1,491.54%-32.55M	-53.98%56.63M	597.75%74.66M	-86.04%-24.52M	-32.45%-21.83M	89.63%-2.05M	257.85%123.06M	72.79%-15M	-221.47%-13.18M	22.86%-16.48M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data